Incline Global Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-51,900
Closed -$15.8M 29
2015
Q2
$15.8M Buy
51,900
+12,900
+33% +$3.85M 3.49% 18
2015
Q1
$11.6M Sell
39,000
-21,500
-36% -$6.13M 2.89% 20
2014
Q4
$15.6M Buy
60,500
+35,500
+142% +$8.87M 4.6% 5
2014
Q3
$6.03M Buy
25,000
+14,000
+127% +$3.13M 1.81% 33
2014
Q2
$2.45M Buy
11,000
+3,700
+51% +$766K 0.92% 32
2014
Q1
$1.5M Sell
7,300
-21,700
-75% -$4.3M 0.82% 28
2013
Q4
$4.87M Buy
+29,000
New +$4.53M 3.12% 20

Other funds holding AGN

Incline Global Management's AGN Position: Q4 2015 in Review

Incline Global Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 117,924 shares — an estimated $32.1M sold.

Incline Global Management first reported a position in AGN in Q4 2013 and held it in 8 quarters. The position peaked at $32.1M in Q3 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Incline Global Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Incline Global Management sold 117,924 Allergan plc shares in Q4 2015, an estimated $32.1M.
  • Incline Global Management first reported a position in Allergan plc in Q4 2013 and held it in 8 quarters.
  • Incline Global Management's Allergan plc position peaked at $32.1M in Q3 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Incline Global Management's 13F filing for Q4 2015, filed 16 Feb 2016.